CTMX — CYTOMX THERAPEUTICS INC

Ownership history in PRUDENTIAL FINANCIAL INC  ·  24 quarters on record

This page tracks every 13F SEC filing in which PRUDENTIAL FINANCIAL INC reported a position in CYTOMX THERAPEUTICS INC (CTMX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2020 Q1)
Avg. % of fund
0.0%
First filed
2017 Q1
Last filed
2025 Q3
Quarters held
24
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 23,300 -2,400 -9.3% 0.00% $74K $3.19
2025 Q2 REDUCED 25,700 -55,800 -68.5% 0.00% $58K $2.27
2025 Q1 ADDED 81,500 +17,200 +26.7% 0.00% $52K $0.64
2024 Q4 ADDED 64,300 +27,800 +76.2% 0.00% $66K $1.03
20 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    CTMX price (monthly, adj. close)

Other funds also holding CTMX

As of 2025 Q4 — sorted by position size

VR Adviser, LLC 3Y 3.27% Kynam Capital Management, LP 3Y 2.44% Commodore Capital LP 3Y 2.18% Exome Asset Management LLC 1.52% ADAR1 Capital Management, LLC 1.29% Ikarian Capital, LLC 3Y 1.06% Elmind Capital, LP 0.88% Vivo Capital, LLC 3Y 7Y 0.79% STEMPOINT CAPITAL LP 0.76% PERCEPTIVE ADVISORS LLC 3Y 7Y 0.74%
← Back to PRUDENTIAL FINANCIAL INC Holdings